D’Antò M, Luiso V, Cuomo V and Ranucci RAN
UOC Internal Medicine, P.O.â�?S.Maria delle Grazieâ�?, Pozzuoli (NA), Italy UOC Emergency Medicine, Az. Osp. Dei Colli, Napoli, Italy
Posters & Accepted Abstracts: Health Sci J
Background and aims: The linkage to care of PWID still remains an important gap in HCV treatment in Southern Italy in particular during pandemic. We evaluated a new model of care to improve the LTC throughout a pathway simplification and decentralization of HCV care with a close collaboration with addiction centers and hospital specialist and use of remote monitoring. Patients and methods: The project started from January 2019 and it is currently ongoing. Four addiction centers of Naples district were involved (Acerra, Pozzuoli, Giugliano, Casavatore). A complete hepatological assessment, including blood chemistry, ultrasound and transient elastography examination, was provided. Hospital specialist confirmed diagnosis and prescribed DAA by visit on site before pandemic and by remote engagement during pandemic. Results: 500 patients were screened, 300 were positive and 200 were treated; 87% were active drugs users and 79% of them were receiving opioid substitution therapy; 30% presented genotype 1a, the 36% 1b and 28% 3a. Everyone was treated with DAAs regimens. Discussion: The SVR was 99% and remote monitoring through phone and video calls was successful.